Astragaloside IV attenuates gestational diabetes mellitus via targeting NLRP3 inflammasome in genetic mice

• Main Authors: Ruixue Zhang (Author), Xuelei Zhang (Author), Baoheng Xing (Author), Jianyong Zhao (Author), Peipei Zhang (Author), Dandan Shi (Author), Fengzhen Yang (Author)
• Format: Book
• Published: BMC, 2019-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background As the most ordinary metabolic disorder during pregnancy, gestational diabetes mellitus (GDM) has become a severe risk for the health of both pregnant female and fetus. Astragaloside IV (AS-IV) is the dominant active component in Astragalus membranaceus. It has been proved that A...